Validity and Reliability Studies of the Indonesian Version of Arrhythmia-Specific Questionnaire in Tachycardia and Arrhythmia (ASTA)
Background: The Arrhythmia-Specific Questionnaire in Tachycardia and Arrhythmia (ASTA) was developed in Sweden using English which may pose cultural and language barriers for Indonesian patients. As such, we aimed to translate the original ASTA into Indonesian, then assess its validity and reliability. Methods: Translation of the ASTA from English to Indonesian was done using forward and backward translation. The final version was then validated with the Short Form-36 (SF-36) questionnaire. Test-retest reliability study was done in a 7-14-day interval. Results: The Indonesian version of ASTA was deemed acceptable by a panel of researchers with Cronbach’s α of 0.816 and Intraclass Correlation Coefficient (ICC) ranging from 0.856-0.983. In a comparison to the SF-36, the medication utilization domain was poorly correlated with role limitations due to physical health (r:0.384; p<0.01) and pain (r:-0.317; p<0.05). The arrhythmia-specific symptoms domain was poorly correlated with role limitations due to emotional problems (r:0.271; p<0.05). In addition, the health-related quality of life (HRQOL) domain was poorly correlated with role limitations due to physical health (r:0.359; p<0.01) and emotional problems (r:0.348; p<0.01), also total SF-36 score (r:-0.367; p<0.01). The ASTA total score was poorly correlated with role limitations due to physical health (r:0.37; p<0.01), and emotional problems (r:0.376; p<0.01), also total SF-36 score (r:-0.331; p<0.01). Conclusion: The Indonesian version of ASTA has good internal and external validity as well as good reliability. Both the physical and mental domains of ASTA are correlated with role limitations due to emotional problems and SF-36 total score.
Cannavan PMS, Cannavan FPS, Walfridsson U, Lopes MHBM. Translation and validation of the arrhythmia-specific questionnaire in tachycardia and arrhythmia (ASTA) to the Brazilian context: An instrument focusing on arrhythmia symptoms. Cardiol Res Pract. 2020;2020:1–7.
Morillo CA, Banerjee A, Perel P, Wood D, Jouven X. Atrial fibrillation: The current epidemic. J Geriatr Cardiol. 2017;14(3):195–203.
Taheri L, Poorgholami F, Zare A, Jahromi MK. Quality of life in patients with atrial fibrillation: An intervention. Nurs Crit Care. 2020;15(6):7–11.
Jones J, Stanbury M, Haynes S, et al. Importance and assessment of quality of life in symptomatic permanent atrial fibrillation: Patient focus groups from the RATE-AF trial. Cardiol. 2020;145(10):666–75.
Vintila A, Stanciu A, Horumba M, Vintila V, Lupusoru M, Gurghean A. Impact of atrial fibrillation on quality of life. J Hypertens. 2019;37(June):2019.
Kotecha D, Ahmed A, Calvert M, Lencioni M, Terwee CB, Lane DA. Patient- reported outcomes for quality of life assessment in atrial fibrillation: A systematic review of measurement properties. PLoS One. 2016;11(11):1–13.
Walfridsson U, Arestedt K, Stromberg A. Development and validation of a new Arrhythmia-Specific questionnaire in Tachycardia and Arrhythmia (ASTA) with focus on symptom burden. Health Qual Life Outcomes. 2012;10:1–10.
Walfridsson U, Stromberg A, Arestedt K. Development and validation of an arrhythmia-specific scale in tachycardia and arrhythmia with focus on health- related quality of life. J Cardiovasc Nurs. 2015;30(2):98–108.
Daud KAM, Khidzir NZ, Ismail AR, Abdullah FA. Validity and reliability of instrument to measure social media skills among small and medium entrepreneurs at Pengkalan Datu River. Int J Dev Sustain. 2018;7(3):1026–37.
Han X. On statistical measures for data quality evaluation. J Geogr Inf Syst. 2020;12(03):178–87.
Rienstra M, Lubitz SA, Mahida S, et al. Symptoms and functional status of patients with atrial fibrillation: State of the art and future research opportunities. Circulation. 2012;125(23):2933–43.
Lindberg T, Sanmartin Berglund J, Elmståhl S, Bohman DM. Older individuals’ need for knowledge and follow-up about their chronic atrial fibrillation, lifelong medical treatment and medical controls. Scand J Caring Sci. 2017;31(4):1022–30.
Barbaglia G, Adroher ND, Vilagut G, et al. Health conditions and role limitation in three European Regions: a public-health perspective. Gac Sanit. SESPAS; 2017;31(1):2–10.
Kupper N, van den Broek KC, Widdershoven J, Denollet J. Subjectively reported symptoms in patients with persistent atrial fibrillation and emotional distress. Front Psychol. 2013;4(April):1–9.
Carlisle MA, Fudim M, DeVore AD, Piccini JP. Heart failure and atrial fibrillation, like fire and fury. JACC Hear Fail. 2019;7(6):447–56.
Hilow H, Whibley D, L.Kratz A, Ghanbar H. A focus group study to inform design of a symptom management intervention for adults with atrial fibrillation Author links open overlay panel. Cardiovasc Digit Heal J. 2021;2(5):246–55.
Gayman MD, Turner RJ, Cui M. Physical limitations and depressive symptoms: Exploring the nature of the association. Journals Gerontol - Ser B Psychol Sci Soc Sci. 2008;63(4):219–28.
Lampert R, Burg MM, Jamner LD, Dziura J, Brandt C, Li F. Effect of beta-blockers on triggering of symptomatic atrial fibrillation by anger or stress. Heart Rhythm. 2019;16(8):1167–73.
Bekfani T, Nisser J, Derlien S, et al. Psychosocial factors, mental health, and coordination capacity in patients with heart failure with preserved ejection fraction compared with heart failure with reduced ejection fraction. ESC Hear Fail. 2021;8(4):3268–78.
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution 4.0 International License.